PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Child Science 2017; 07(01): e146-e150
DOI: 10.1055/s-0037-1608713
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Value of Resistin in Early Onset Neonatal Sepsis

Abdurrahman Avar Ozdemir
1   Division of Neonatology, Department of Pediatrics, Istanbul Medicine Hospital, Biruni University, Istanbul, Turkey
,
Yusuf Elgormus
2   Department of Pediatrics, Istanbul Medicine Hospital, Biruni University, Istanbul, Turkey
› Institutsangaben
Weitere Informationen

Publikationsverlauf

25. August 2017

10. Oktober 2017

Publikationsdatum:
30. November 2017 (online)

   Lizenzen und Reprints

Abstract

The diagnosis of neonatal sepsis is usually difficult because the sign and symptoms are nonspecific. Although C-reactive protein (CRP) and procalcitonin (PCT) are the most commonly used auxiliary tests, they are not reliable enough markers to be used for diagnosis of neonatal sepsis. This study aimed to evaluate the efficacy of resistin in diagnosing early onset neonatal sepsis and to compare its effectiveness to CRP and PCT. This prospective study was performed in the neonatal intensive care unit of Medicine Hospital between June and September 2016. Twenty-nine infants in the sepsis group and 33 infants in the control group were recruited. The Töllner scoring system was used for clinical signs. The hematologic parameters were evaluated using the Manroe and Rodwell scoring systems. The blood samples for CRP, PCT, and resistin were collected at admission (T0), and at 72 hours (T3). Mean plasma resistin level at T0 was 54.20 ± 39.3 ng/mL in the sepsis group and 34.92 ± 6.9 ng/mL in the control group. The sensitivity at T0 for resistin was 76%, and the specificity was 67%. The values of area under the curve (AUC) for CRP, PCT, and resistin were 0.84, 0.66, and 0.72, respectively. We found the diagnostic value of resistin to be lower than CRP, although its plasma levels were elevated. Therefore, we propose that resistin has limited value in diagnosis and follow-up of early-onset neonatal sepsis.

Keywords

newborn - neonatal sepsis - resistin
 

  • References

  • 1 Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27 (01) 21-47
    CrossrefPubMedGoogle Scholar
  • 2 Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 2012; 102 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 3 Delanghe JR, Speeckaert MM. Translational research and biomarkers in neonatal sepsis. Clin Chim Acta 2015; 451 (Pt A): 46-64
    CrossrefPubMedGoogle Scholar
  • 4 Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 2013; 30 (02) 131-141
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 5 Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence 2014; 5 (01) 170-178
    CrossrefPubMedGoogle Scholar
  • 6 Al-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res 2013; 18: 12
    CrossrefPubMedGoogle Scholar
  • 7 Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006; 64 (04) 355-365
    PubMedGoogle Scholar
  • 8 Hillenbrand A, Weiss M, Knippschild U, Wolf AM, Huber-Lang M. Sepsis-induced adipokine change with regard to insulin resistance. Int J Inflamm 2012; 2012: 972368
    PubMedGoogle Scholar
  • 9 Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255 (04) 439-447
    CrossrefPubMedGoogle Scholar
  • 10 Pang SS, Le YY. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 2006; 3 (01) 29-34
    PubMedGoogle Scholar
  • 11 Suragani M, Aadinarayana VD, Pinjari AB. , et al. Human resistin, a proinflammatory cytokine, shows chaperone-like activity. Proc Natl Acad Sci U S A 2013; 110 (51) 20467-20472
    CrossrefPubMedGoogle Scholar
  • 12 Sundén-Cullberg J, Nyström T, Lee ML. , et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 2007; 35 (06) 1536-1542
    CrossrefPubMedGoogle Scholar
  • 13 Kusanovic JP, Romero R, Mazaki-Tovi S. , et al. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonatal Med 2008; 21 (12) 902-916
    CrossrefPubMedGoogle Scholar
  • 14 Kader NA, El-Din FA, Khatab EA, ELAbd NE. Does plasma resistin level have a role in predicting inflammatory bowel disease activity?. Indian J Gastroenterol 2010; 29 (03) 126-127
    CrossrefPubMedGoogle Scholar
  • 15 Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982; 138 (04) 331-337
    CrossrefPubMedGoogle Scholar
  • 16 Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95 (01) 89-98
    CrossrefPubMedGoogle Scholar
  • 17 Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr 1988; 112 (05) 761-767
    CrossrefPubMedGoogle Scholar
  • 18 Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309 (02) 286-290
    CrossrefPubMedGoogle Scholar
  • 19 Lee S, Lee HC, Kwon YW. , et al. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab 2014; 19 (03) 484-497
    CrossrefPubMedGoogle Scholar
  • 20 Ziora D, Machura E, Ziora KT, Swietochowska E, Oswiecimska JM, Kasperska-Zajac A. Serum resistin levels are elevated in schoolchildren with atopic asthma. Neuroendocrinol Lett 2013; 34 (03) 212-216
    PubMedGoogle Scholar
  • 21 Huang H, Shen E, Tang S. , et al. Increased serum resistin levels correlate with psoriasis: a meta-analysis. Lipids Health Dis 2015; 14: 44
    CrossrefPubMedGoogle Scholar
  • 22 Huang Q, Tao SS, Zhang YJ. , et al. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 2015; 34 (10) 1713-1720
    CrossrefPubMedGoogle Scholar
  • 23 Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009; 13 (03) R95
    CrossrefPubMedGoogle Scholar
  • 24 Vassiliadi DA, Tzanela M, Kotanidou A. , et al. Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care 2012; 27 (04) 400-409
    CrossrefPubMedGoogle Scholar
  • 25 Johansson L, Linner A, Sunden-Cullberg J, Treutiger CJ, Norrby-Teglund A. Resistin in severe bacterial infections. Crit Care 2007; 11 (Suppl. 04) P10
    PubMedGoogle Scholar
  • 26 Macdonald SPJ, Stone SF, Neil CL. , et al. Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department. PLoS One 2014; 9 (10) e110678
    CrossrefPubMedGoogle Scholar
  • 27 Cekmez F, Canpolat FE, Cetinkaya M. , et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw 2011; 22 (02) 113-117
    PubMedGoogle Scholar
  • 28 Gokmen Z, Ozkiraz S, Kulaksizoglu S. , et al. Resistin--a novel feature in the diagnosis of sepsis in premature neonates. Am J Perinatol 2013; 30 (06) 513-517
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 29 Aliefendioglu D, Gürsoy T, Çağlayan O, Aktaş A, Ovalı F. Can resistin be a new indicator of neonatal sepsis?. Pediatr Neonatol 2014; 55 (01) 53-57
    CrossrefPubMedGoogle Scholar